Loading insider details...
Beta
Latest Form 4 (Apr 6, 2026): Exercise/Conversion of 758,001 RNAC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 6, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Exercise/Conversion | 758,001 | n/a |
| Jan 6, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 2,600 | n/a |
| Jan 6, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 2,600 | n/a |
| Oct 15, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Exercise/Conversion | 1,518,373 | n/a |
| Apr 11, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Exercise/Conversion | 491,853 | n/a |
| Jan 4, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 178,000 | n/a |
| Nov 15, 2023 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 257,739 | n/a |